Oncology & Cancer

DNA test could broaden access to cervical cancer screening

Rice University bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more ...

Oncology & Cancer

England moves to a single-dose HPV vaccine

The HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Oncology & Cancer

Addressing cancer concerns in the LGBTQ+ community

During June, many cities and towns around the U.S. and the world celebrate and raise awareness of the LGBTQ+ community's accomplishments and the ongoing fight for equality and acceptance.

page 12 from 40